The relationships of the quality and quantity of dietary protein, the level of fasting serum and 8-hour overnight urine free amino acids and blood pressure were studied in three natural Chinese populations. The results showed that the ratio of dietary animal protein/total dietary protein, the ratio of dietary protein/dietary sodium, serum and urine taurine, lysine etc were inversely associated with blood pressure significantly. Alanine was positively associated with blood pressure. Most serum free amino acids were positively correlated with the ratio of dietary protein/dietary sodium. Urine taurine, lysine and asparagine were positively correlated with dietary protein, dietary and urine sodium significantly. These results suggested that high quality protein which is rich in taurine, lysine etc might prevent hypertension.

BACKGROUND: Hepatitis B virus (HBV) recurrence following liver transplantation has been difficultly treated, and antiviral therapy following HBV recurrence has been less reported yet.OBJECTIVE: To investigate the antiviral therapy using Adefovir + Lamivudine + anti-hepatis B immunoglobulin on liver functional improvement following liver transplantation.METHODS: A total of 208 cases with hepatitis B-related end-stage liver disease following liver transplantation were selected from Liver Transplantation Center of Fuzhou General Hospital of Nanjing Military Area Command of Chinese PLA from January 2005 to October 2008. All patients were treated with Lamivudine + anti-hepatis B immunoglobulin so as to prevent from HBV recurrence. At 6-43 months after following up, HBV recurrence was found in 19 cases, including 13 with positive HBeAg and 8 with YMDD mutation. The 19 patients were treated with Adefovir based on the application of Lamivudine + anti-hepatis B immunoglobulin.RESULTS AND CONCLUSION: At 12, 24, and 48 weeks after treatment, DNA and glutamic-pyruvic transaminase of 19 cases were significantly decreased (P < 0.01). After 48-week treatment, recovery rate of glutamic-pyruvic transaminase, negativity rate of HBeAg, and negativity rate of HBV DNA were 84.1 %, 76.92%, and 78.9%, respectively. The results demonstrated that the application of Adefovir + Lamivudine + anti-hepatis B immunoglobulin effectively inhibited viral replication and prevented HBV recurrence following liver transplantation.